Gene, Cell, + RNA Therapy Landscape Q4 2023 Report

Cell and Gene Therapy Global Regulatory Report

The first Cell and Gene Therapy Regulatory Report from Citeline and ISCT provides a global overview of the cell and gene therapy landscape.

CGT Development Is Booming, but Manufacturing Workforce Must Keep Up

Due to unprecedented growth in the development of cell and gene therapies, there is high demand for certain workforce roles.

Gene, Cell, + RNA Therapy Landscape Q3 2023 Report

Q3 2023 saw 3,866 therapies in development; 53% of those were gene therapies, 25% RNA therapies, and 22% non-genetically modified cell therapies.